NDC Package 51991-890-33 Erlotinib

Erlotinib Hydrochloride Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51991-890-33
Package Description:
30 TABLET, FILM COATED in 1 BOTTLE
Product Code:
Proprietary Name:
Erlotinib
Non-Proprietary Name:
Erlotinib Hydrochloride
Substance Name:
Erlotinib Hydrochloride
Usage Information:
None.
11-Digit NDC Billing Format:
51991089033
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 603203 - erlotinib 100 MG Oral Tablet
  • RxCUI: 603203 - erlotinib 100 MG (equivalent to erlotinib HCl 109.3 MG) Oral Tablet
  • RxCUI: 603206 - erlotinib 150 MG Oral Tablet
  • RxCUI: 603206 - erlotinib 150 MG (equivalent to erlotinib HCl 163.9 MG) Oral Tablet
  • RxCUI: 603208 - erlotinib 25 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Breckenridge Pharmaceutical, Inc.
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA208488
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    11-05-2019
    End Marketing Date:
    07-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51991-890-33?

    The NDC Packaged Code 51991-890-33 is assigned to a package of 30 tablet, film coated in 1 bottle of Erlotinib, a human prescription drug labeled by Breckenridge Pharmaceutical, Inc.. The product's dosage form is tablet, film coated and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package.

    Is NDC 51991-890 included in the NDC Directory?

    Yes, Erlotinib with product code 51991-890 is active and included in the NDC Directory. The product was first marketed by Breckenridge Pharmaceutical, Inc. on November 05, 2019.

    What is the NDC billing unit for package 51991-890-33?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

    What is the 11-digit format for NDC 51991-890-33?

    The 11-digit format is 51991089033. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-251991-890-335-4-251991-0890-33